Bone Marrow Transplant in Hyderabad

Bone marrow transplant in Hyderabad is commonly quoted between ₹10 lakh and ₹35 lakh depending on the centre and the type of transplant. At CION the indicative range is ₹8 lakh to ₹15 lakh: roughly ₹8–11 lakh for an autologous transplant using the patient's own stem cells, and roughly ₹11–15 lakh for an allogeneic transplant from a matched sibling donor. Half-matched and unrelated-donor transplants are assessed case by case. These figures are indicative and are not a quotation, and do not include family accommodation, travel, or medication after discharge.

No. There is no operation, no scalpel and no general anaesthesia for the transplant itself. The stem cells are given as an infusion through a central line — a soft tube placed into a large vein — in much the same way as a blood transfusion. The patient is awake and sitting up, and it takes a few hours. What makes people unwell is the conditioning chemotherapy given in the days beforehand, and the weeks of low immunity afterwards, not the transplant.

No. Bone marrow is never taken from the spine, and donating does not cause paralysis or permanent weakness. Most donors today give stem cells through apheresis — blood is drawn from one arm, passed through a machine that separates out the stem cells, and returned through the other arm. There is no surgery and nothing goes into the back. When marrow itself is collected, it is taken from the hip bone, under anaesthesia, through a needle. The body replaces the donated cells within a few weeks, and donors return to normal work and normal life.

Possibly not. Transplant is not the standard treatment for every blood cancer. Many people with lymphoma are treated with chemotherapy and immunotherapy alone and never need one. Most people with chronic myeloid leukaemia today take a daily tablet at home and rarely need a transplant. In acute myeloid leukaemia, whether a transplant is advised depends heavily on the genetic risk group of the disease and how it responds to first treatment. Before committing, it is entirely reasonable to ask for a second opinion with full molecular and cytogenetic review.

There is. A full sibling has roughly a one in four chance of being a complete HLA match, so most families do not have one. But a parent or a child is always at least a half-match, because you inherit half of your HLA type from each parent. Half-matched, or haploidentical, transplant is now well established. A family with no sibling match is not out of options, and unrelated donor registries exist as well. Start with a haematology consultation rather than assuming the worst.

There are four, named by where the stem cells come from. An autologous transplant uses your own stem cells, collected and given back. An allogeneic transplant uses cells from a fully HLA-matched sibling. A haploidentical transplant uses a half-matched parent or child. An unrelated-donor or cord-blood transplant uses cells from a registry donor or banked umbilical cord blood. The type determines the cost, the risks and the length of stay.

Your HLA type — the set of markers a donor must match — comes in two halves, one inherited from each parent. Each parent has two halves to give, so there are four possible combinations a child can inherit. Two siblings match fully only when they happen to inherit the same combination, which is why the chance is about one in four. The same arithmetic explains why a parent or child is always exactly a half-match.

A haploidentical transplant uses stem cells from a parent or a child, who is always at least a half-match because you inherit half your HLA type from each parent. It is now well established and performed routinely, and it is the reason a family with no matched sibling is not a family without a donor. If you have a living parent or an adult child, you have a potential donor.

Under Aarogyasri and PMJAY, eligible treatment at empanelled centres may be supported, subject to eligibility, and private insurance is accepted cashless where applicable. Coverage for transplant varies by scheme and by case, so the honest step is to have our counsellors check what applies to your specific situation and map out what you would actually pay, rather than assuming either that everything is covered or that nothing is.

Isolation is not a hospital rule made for convenience — it is the reason the transplant survives. The conditioning therapy clears the old bone marrow, so for roughly two weeks the patient has almost no infection-fighting white cells at all. In that window an ordinary cold, or a common stomach bug carried in on a visitor's hands, can become life-threatening. Once the new stem cells engraft and blood counts recover, restrictions ease. The team explains exactly when and how you can visit, and video calls are almost always possible throughout.

In a donor transplant, the arriving cells bring the donor's immune system with them, and it can sometimes treat the recipient's body as foreign — attacking the skin, gut or liver. This is graft-versus-host disease. It can be mild or severe, it is monitored closely, and it is treatable. Importantly, the same donor immune system also attacks any remaining cancer cells (the graft-versus-tumour effect), which is a large part of why a donor transplant works at all.

No. What is transplanted is the blood-forming system — the part of the body that produces red cells, white cells and platelets. A person's brain, memory, personality, character and identity are entirely unaffected. The one real change is that the recipient's blood group may gradually become the donor's, because blood group is determined by the marrow. It is a medical treatment for one organ system, not a transformation of the person.

Donating stem cells is safe and well tolerated. It does not affect fertility, does not affect the ability to have children later, and does not cause cancer or increase a donor's risk of it. The body replaces donated cells within a few weeks. Most donors return to normal activity within days of apheresis, or within a week or two after a marrow harvest, including physical work.

Most people are out of hospital within four to six weeks, but the immune system takes months to rebuild. In the first year a patient typically needs thirty or more follow-up visits — blood counts, transfusions, medication reviews and checks for GvHD and infection — twice weekly at first, then weekly, then fortnightly. CION can carry out much of this follow-up at your nearest centre so you do not have to travel to Hyderabad repeatedly while your immune system is still recovering.

Many people do return to work, study and family life. Recovery is gradual rather than sudden: most people are out of hospital within four to six weeks, but the immune system takes months to rebuild and follow-up continues for a year or more. During the first few months, crowds, raw food and infection risk have to be managed carefully. How well someone recovers depends on their condition, their age, the type of transplant and whether complications occur.

Your evaluation, haematology care, transplant decision and follow-up are led by CION's own team. The transplant itself is performed at accredited partner transplant centres in Hyderabad, under a formal arrangement, with the same haematology team managing your case throughout. This is stated plainly so you know exactly what CION delivers directly and what it coordinates — and it is also why routine follow-up can happen close to your home.

Outcomes vary enormously with the condition, the patient's age, the type of donor and — above all — how well the disease had responded to treatment before the transplant. A young person with thalassaemia and a matched sibling is in a very different position from an older person with leukaemia that has already returned. A single headline percentage that ignores all of that is close to meaningless. A haematologist who has read your reports can give you figures that actually apply to you.

Traditional practices may bring comfort, and many families find real meaning in them. But with blood cancers — acute leukaemia in particular — time is the one thing that cannot be recovered, because it can progress over days and weeks, not months. Using traditional remedies instead of treatment spends exactly the window in which treatment works best. If you want to continue a traditional practice alongside medical treatment, tell your haematologist: some are safe alongside treatment and some interfere with it.